Award
Delivery Order #SPE2D326F199Y
DLA Orders Provera Tablets from Pfizer Under Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$195.95
Ceiling
$195.95
Awarded
June 17, 2026
Period of Performance
Jun 17, 2026 – Jun 18, 2026
Identifier
SPE2D326F199Y
NAICS
325412
This delivery order, issued under the Defense Logistics Agency’s long-term pharmaceutical supply agreement with Pfizer Inc., covers Provera (medroxyprogesterone acetate) 2.5 mg tablets in 100-count packaging. Pfizer is a pharmaceutical manufacturer supplying medicines for government and military needs. The order supports access to prescription medication through the agency’s established procurement program; the record does not specify the intended patients or further delivery requirements. The parent agreement was competitively awarded, but the record does not state the competition method for this individual order. The parent vehicle runs over a multi-year period, and this order has a brief performance window. No acquisition program, subcontractors, related prior orders, or original solicitation details are provided.
Description
4572166139!PROVERA 2.5 MG TABLET 100S